• Seres Therapeutics' (MCRB) Buy Rating Reaffirmed at Canaccord Genuity Group

    Source: Buzz FX / 14 Nov 2024 11:31:18   America/Chicago


    Seres Therapeutics' (MCRB) Buy Rating Reaffirmed at Canaccord Genuity Group Written by MarketBeat November 14, 2024 Share Link copied to clipboard. Seres Therapeutics ( NASDAQ:MCRB - Get Free Report ) 's stock had its "buy" rating reiterate
    Read more...
Share on,